# VESICARE LS
> **NDA209529** · New Drug Application · Sponsor: ASTELLAS · Approved 2020-05-26
## Drug
- **FDA Application Number:** NDA209529
- **Application type:** New Drug Application
- **Brand name:** VESICARE LS
- **Generic name:** SOLIFENACIN SUCCINATE
- **Active ingredients:** SOLIFENACIN SUCCINATE
- **Dosage form:** SUSPENSION
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** ASTELLAS
- **Manufacturer:** Astellas Pharma US, Inc.
- **First approval:** 2020-05-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209529)
---
*MORVS · CC0 1.0*